BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11949740)

  • 1. An organic psychosis due to a venlafaxine-propafenone interaction.
    Pfeffer F; Grube M
    Int J Psychiatry Med; 2001; 31(4):427-32. PubMed ID: 11949740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of serotonin syndrome caused by venlafaxine and lithium.
    Mekler G; Woggon B
    Pharmacopsychiatry; 1997 Nov; 30(6):272-3. PubMed ID: 9442552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manic switch and serotonin syndrome with venlafaxine-lithium-valproate association.
    Liberek C; Aubry JM; Baud P
    Therapie; 2006; 61(6):531-3. PubMed ID: 17348610
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development of (hypo)mania during discontinuation of venlafaxine in two patients with bipolar disorder].
    Tak LM; Stevens AW
    Tijdschr Psychiatr; 2013; 55(10):795-800. PubMed ID: 24166339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suspected complication of treatment with venlafaxine.
    Wilson R; Jenkins P
    J Clin Psychopharmacol; 1997 Aug; 17(4):323. PubMed ID: 9241015
    [No Abstract]   [Full Text] [Related]  

  • 6. Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation.
    Gareri P; De Fazio P; Gallelli L; De Fazio S; Davoli A; Seminara G; Cotroneo A; De Sarro G
    Ann Pharmacother; 2008 Mar; 42(3):434-8. PubMed ID: 18303146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Even low-dose treatment of venlafaxine may provoke recurrence of hypertension in an Asian patient?
    Bahk WM; Pae CU; Chae JH; Jun TY; Kim KS
    Gen Hosp Psychiatry; 2001; 23(4):232-4. PubMed ID: 11569474
    [No Abstract]   [Full Text] [Related]  

  • 8. Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.
    Gitlin MJ
    J Clin Psychopharmacol; 1997 Feb; 17(1):66-7. PubMed ID: 9004070
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible venlafaxine-induced mania.
    Stoner SC; Williams RJ; Worrel J; Ramlatchman L
    J Clin Psychopharmacol; 1999 Apr; 19(2):184-5. PubMed ID: 10211922
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxic interaction of venlafaxine and isocarboxazide.
    Klysner R; Larsen JK; Sørensen P; Hyllested M; Pedersen BD
    Lancet; 1995 Nov; 346(8985):1298-9. PubMed ID: 7475741
    [No Abstract]   [Full Text] [Related]  

  • 11. Venlafaxine-associated mania.
    Shulman RB; Scheftner WA; Nayudu S
    J Clin Psychopharmacol; 2001 Apr; 21(2):239-41. PubMed ID: 11270924
    [No Abstract]   [Full Text] [Related]  

  • 12. Venlafaxine-associated hypomania in unipolar depression.
    Chand PK; Kalyani GS; Murthy P
    Can J Psychiatry; 2004 Jul; 49(7):496. PubMed ID: 15362257
    [No Abstract]   [Full Text] [Related]  

  • 13. Venlafaxine and reversible blepharoedema.
    Reif A; Pfuhlmann B
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):413-4. PubMed ID: 12466039
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder.
    Lobello KW; Preskorn SH; Guico-Pabia CJ; Jiang Q; Paul J; Nichols AI; Patroneva A; Ninan PT
    J Clin Psychiatry; 2010 Nov; 71(11):1482-7. PubMed ID: 20441720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venlafaxine withdrawal in organic anxiety disorder.
    Jhirwal OP; Chakrabarti S
    Indian J Med Sci; 2003 Dec; 57(12):559-60. PubMed ID: 14701949
    [No Abstract]   [Full Text] [Related]  

  • 16. [Possible serotonin syndrome associated with administration of venlafaxine and tramadol].
    Albiñana Pérez MS; Cea Pereira L; Bilbao Salcedo J; Rodríguez Penín I
    Farm Hosp; 2012; 36(6):548. PubMed ID: 23461451
    [No Abstract]   [Full Text] [Related]  

  • 17. Withdrawal reactions associated with venlafaxine.
    Parker G; Blennerhassett J
    Aust N Z J Psychiatry; 1998 Apr; 32(2):291-4. PubMed ID: 9588310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of high-dose venlafaxine-related psychosis.
    Dennison EA; Raidoo BM; Cruz R; Raidoo D
    J Clin Psychopharmacol; 2013 Feb; 33(1):134-6. PubMed ID: 23288238
    [No Abstract]   [Full Text] [Related]  

  • 19. Venlafaxine and bilateral acute angle closure glaucoma.
    Ng B; Sanbrook GM; Malouf AJ; Agarwal SA
    Med J Aust; 2002 Mar; 176(5):241. PubMed ID: 11999245
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine.
    Prior FH; Isbister GK; Dawson AH; Whyte IM
    Med J Aust; 2002 Mar; 176(5):240-1. PubMed ID: 11999244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.